Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03427736 · ClinicalTrials.gov registry record

Anesthetics and Analgesics in Children

A clinical trial of Pain and Anesthesia, sponsored by Chi Dang Hornik.

Recruiting
Registry status
460
Enrollment target
13
Study locations

NCT03427736: Recruiting study of Pain and Anesthesia, sponsored by Chi Dang Hornik.

NCT03427736 is a study of Pain and Anesthesia that is actively recruiting participants, run by Chi Dang Hornik. The registered enrollment target is 460 participants, above the 303-participant average among 374 other Pain trials with a reported enrollment target (52% higher). The trial reports 13 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03427736, a study of Pain and Anesthesia, is actively recruiting participants, sponsored by Chi Dang Hornik.

RECRUITING
Registry status
460 participants
Enrollment target
13
Study locations

Study Summary

The purpose of this study is to characterize the pharmacokinetic (PK) and safety profile of anesthetics and analgesics in children and adolescents.

Conditions Studied

Interventions

  • DRUG Ketamine
  • DRUG Oxycodone
  • DRUG Hydromorphone
  • DRUG Morphine
  • DRUG Ketorolac Tromethamine

Study Locations (13)

Missouri

  • Cardinal Glennon Children's Hospital - St Louis
  • Washington University School of Medicine - St Louis

Texas

  • Dell Children's Medical Center of Texas - Austin
  • Baylor College of Medicine - Houston

California

  • Lucile Packard Children's Hospital - Stanford

Colorado

  • Children's Hospital Colorado - Aurora

Delaware

  • Alfred I. DuPont Hospital for Children - Wilmington

Illinois

  • Ann and Robert H. Lurie Childrens Hospital of Chicago - Chicago

North Carolina

  • Duke University Medical Center - Durham

Oregon

  • Oregon Health and Science University - Portland

Trial Details

FieldValue
Enrollment Target 460 participants
Start Date 2018-12-13
Est. Completion 2026-09-09
Chi Dang Hornik

1 total trials

What NCT03427736 shows while recruiting

NCT03427736 is an observational study that tracks outcomes without assigning an intervention. The registered 460 participants enrollment target is mid-sized for trials with a published cap, above the 303-participant average among 374 other Pain trials with a reported enrollment target (52% higher).

The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 5 interventions - of which Ketamine is the first listed.

NCT03427736 lists 13 locations in 11 states (Missouri, Texas, California).

Frequently Asked Questions

What is clinical trial NCT03427736 about?

NCT03427736 is a clinical study titled "Anesthetics and Analgesics in Children". The purpose of this study is to characterize the pharmacokinetic (PK) and safety profile of anesthetics and analgesics in children and adolescents.

What is the current status of trial NCT03427736?

This trial is currently recruiting. The enrollment target is 460 participants. The study started on 2018-12-13. Estimated completion is 2026-09-09.

What conditions does trial NCT03427736 study?

This clinical trial studies the following conditions: Pain, Anesthesia.

What interventions are being tested in trial NCT03427736?

The interventions under investigation include: Ketamine (DRUG), Oxycodone (DRUG), Hydromorphone (DRUG), Morphine (DRUG), Ketorolac Tromethamine (DRUG).

Who is sponsoring clinical trial NCT03427736?

This trial is sponsored by Chi Dang Hornik, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03427736 being conducted?

This trial has 13 study locations across California, Colorado, Delaware, Illinois, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03427736's enrollment target sits among peer trials

460 38th of 374 higher than 337 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02977780 · 460 participants · Phase 2

    INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)

  • NCT03819933 · 460 participants · NA

    Optimizing Family Counseling for Anticipated Extremely Preterm Delivery

  • NCT04621279 · 460 participants

    Cool Prime Comparative Effectiveness Study for Mild HIE

  • NCT05123482 · 460 participants · Phase 1

    A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03427736, the US trial registry maintained by the National Library of Medicine. NCT03427736 (mid enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.